This unique, half-day event will have key leaders across U.K. biomedical science discussing the challenges and opportunities to boosting life sciences amid a time of major change as the U.K. approaches a future outside of the European Union.
| | | | | | Dear Colleague,
Please join us in London for the fourth annual FierceBiotech Executive Summit: London on October 30, 2018 at the Royal Society of Medicine. This unique, half-day event will have key leaders across U.K. biomedical science discussing the challenges and opportunities to boosting life sciences amid a time of major change as the U.K. approaches a future outside of the European Union. Register now and reserve your spot at the Summit - seats are limited.
In addition to networking opportunities, the Executive Summit will feature multiple panel discussions and a fireside chat. Panel One / Challenges and Opportunities for Life Science Post-Brexit
Dr. Chris Doherty // Managing Director // Alderley Park
Matthew Durdy (High Honors), MA (Oxon.) FCSI // Chief Business Officer of the Cell and Gene Therapy // Catapult
Dr. Peter Jackson // Executive Director // The AMR Centre Ben Adams (Moderator) // Senior Editor // FierceBiotech
Fireside Chat
Steve Bates // CEO // BioIndustry Association
Ben Adams (Moderator) // Senior Editor // FierceBiotech
Panel Two / Tapping Britain's Digital Healthcare Industry
Dr. Munna Choudhury // Management Consultant // Accenture Carly Helfand (Moderator) // Senior Editor // FiercePharma Stay tuned for additonal speaker announcements in the coming weeks! I look forward to seeing you in London. Best regards,
Rebecca Willumson
Publisher
FierceBiotech & FiercePharma
- If you have any questions about this event, please contact [email protected]. | | | | This blast was sent on behalf of FierceBiotech. Click here to unsubscribe or to manage your subscriptions. ©2018 FierceMarkets, a division of Questex, LLC. All rights reserved. 1900 L St NW | Washington, DC | 20036 www.questex.com | | |
|
.
